TrialsgrambetaRCTs are beautiful

HIV

Treatment-as-prevention (HPTN 052), universal ART (START), U=U (PARTNER) and long-acting injectable PrEP (HPTN 083).

  • 2021HPTN 083⁠Long-acting PrEPIn 4,566 cisgender MSM and transgender women at high risk of HIV, long-acting injectable cabotegravir every 8 weeks reduced HIV acquisition compared with daily oral TDF/FTC.HR 0.34Read →
  • 2019PARTNER / PARTNER2⁠U=UIn ≥1,000 serodifferent couples, HIV transmission during condomless sex when the HIV+ partner had viral load <200 copies/mL produced zero phylogenetically linked transmissions across ≥76,000 condomless sex acts.Read →
  • 2015START Core⁠Universal early ARTIn 4,684 ART-naïve adults with CD4 >500/µL, immediate antiretroviral therapy reduced serious AIDS and non-AIDS events compared with deferred ART.HR 0.43Read →
  • 2011HPTN 052 Core⁠Treatment as preventionIn 1,763 HIV-serodiscordant couples, early antiretroviral therapy of the HIV-positive partner reduced linked HIV transmission compared with delayed ART.Read →